Patterns of p53 immunoreactivity in endometrial carcinomas: ‘all or nothing’ staining is of importance
Authors:
- 22 August 2011
- journal article
- letter
- Published by Wiley in Histopathology
- Vol. 59 (4) , 786-788
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Novel staining pattern of p53 in Barrett’s dysplasia – the absent patternHistopathology, 2010
- The biological and clinical value of p53 expression in pelvic high‐grade serous carcinomasThe Journal of Pathology, 2010
- High-Grade Endometrial Carcinoma: Serous and Grade 3 Endometrioid Carcinomas Have Different Immunophenotypes and OutcomesInternational Journal of Gynecological Pathology, 2010
- IMP3 Distinguishes Uterine Serous Carcinoma From Endometrial Endometrioid AdenocarcinomaAmerican Journal of Clinical Pathology, 2010
- Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovaryThe Journal of Pathology, 2010
- WT1, p53 and hormone receptor expression in uterine serous carcinomaHistopathology, 2009
- Utility of p16 Expression for Distinction of Uterine Serous Carcinomas From Endometrial Endometrioid and Endocervical AdenocarcinomasAmerican Journal of Surgical Pathology, 2009
- The Oncofetal Protein IMP3American Journal of Surgical Pathology, 2008
- Immunohistochemical Overexpression of p16 and p53 in Uterine Serous Carcinoma and Ovarian High-grade Serous CarcinomaInternational Journal of Gynecological Pathology, 2007
- Overexpression of p53 protein is an independent prognostic indicator in human endometrial carcinomaBritish Journal of Cancer, 1996